Results 81 to 90 of about 6,538 (235)

An Algorithm for the Diagnosis and Management of Severe Asthma in Children and Adolescents

Allergy, Volume 81, Issue 1, Page 307-310, January 2026.
Eckard Hamelmann, Bianca Schaub, Susanne Lau, Leonard B. Bacharier   +3 more
wiley   +1 more source

Benralizumab Used for Eosinophilic Inflammation in a Lung Transplant Patient [PDF]

, 2022
A. Reiland, Sarah K. Nicholas, Andreas Schräder, N. Bhatt, Elizabeth A. Moulton, Ernestina Melicoff   +5 more
openalex   +1 more source

Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma

Allergy, Volume 81, Issue 1, Page 277-280, January 2026.
Keita Hirai, Sekiko Uehara, Toshihiro Shirai, Taisuke Akamatsu, Kunihiko Itoh   +4 more
wiley   +1 more source

Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory Endpoints [PDF]

, 2020
Umesh Singh, Jonathan A. Bernstein, Marepalli B. Rao, Karen Berendts, Xiang Zhang, Diya F. Mutasim   +5 more
openalex   +1 more source

Life-threating Asthma Exacerbation Successfully Treated with Benralizumab

Internal medicine
A 52-year-old Japanese man with a history of childhood asthma presented at our emergency department with progressive dyspnea. Despite subcutaneous adrenaline injections, salbutamol nebulization, and intravenous methylprednisolone, the carbon dioxide ...
Suzuka Matsuoka, Kenichiro Kudo, Mayu Goda, Tomoyoshi Inoue, Toki Kitano, Yuto Sasano, Keiichi Fujiwara   +6 more
semanticscholar   +1 more source

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

, 2022
Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, Mirai Matsumura, Hiroki Kobayashi, Akio Nomura, Sayaka Ueno, Takuya Tanimoto, Hiroyuki Maeda, Hiroshi Iwamoto, Noboru Hattori   +10 more
openalex   +2 more sources

Effect of benralizumab treatment on the airway microbiome in COPD

ERJ Open Research
Background One-third of patients with COPD have an eosinophilic inflammatory phenotype. Benralizumab is an afucosylated humanised monoclonal antibody that targets the interleukin-5 receptor α subunit, leading to rapid and near-complete eosinophil ...
Koirobi Haldar, Vijay Mistry, Mathew Richardson, Corinne Hamblet, Maria Jison, Michael R. Barer, Christopher McCrae, Christopher E. Brightling   +7 more
doaj   +1 more source

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma

Journal of Asthma and Allergy, 2019
J Mark FitzGerald,1 Eugene R Bleecker,2 Arnaud Bourdin,3 William W Busse,4 Gary T Ferguson,5 Laura Brooks,6 Peter Barker,6 Ubaldo J Martin6 1Centre for Heart and Lung Health, The Lung Centre Vancouver General Hospital, UBC Institute for Heart and Lung ...
FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ   +7 more
doaj  

Eosinophiles Asthma: Was bringt Benralizumab als Zusatztherapie? [PDF]

, 2017

openalex   +1 more source

Tolerance to acetyl-salicylic acid in NSAID-exacerbated respiratory disease after biological therapies with benralizumab, dupilumab, mepolizumab or omalizumab. [PDF]

, 2023
Juan C. López, Elizabeth Garcia, Ana Maria Calle Alvarez, Jefferson-Antonio Buendía, Jorge Sánchez   +4 more
openalex   +1 more source